These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response. Robson MC; Hill DP; Smith PD; Wang X; Meyer-Siegler K; Ko F; VandeBerg JS; Payne WG; Ochs D; Robson LE Ann Surg; 2000 Apr; 231(4):600-11. PubMed ID: 10749622 [TBL] [Abstract][Full Text] [Related]
4. Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review. Zubair M; Ahmad J Rev Endocr Metab Disord; 2019 Jun; 20(2):207-217. PubMed ID: 30937614 [TBL] [Abstract][Full Text] [Related]
5. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Cianfarani F; Tommasi R; Failla CM; Viviano MT; Annessi G; Papi M; Zambruno G; Odorisio T Br J Dermatol; 2006 Jan; 154(1):34-41. PubMed ID: 16403091 [TBL] [Abstract][Full Text] [Related]
6. Emerging Trends in Therapeutic Algorithm of Chronic Wound Healers: Recent Advances in Drug Delivery Systems, Concepts-to-Clinical Application and Future Prospects. Shao M; Hussain Z; Thu HE; Khan S; de Matas M; Silkstone V; Qin HL; Bukhari SNA Crit Rev Ther Drug Carrier Syst; 2017; 34(5):387-452. PubMed ID: 29256838 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome study of growth factor-treated pressure ulcers. Payne WG; Ochs DE; Meltzer DD; Hill DP; Mannari RJ; Robson LE; Robson MC Am J Surg; 2001 Jan; 181(1):81-6. PubMed ID: 11248182 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow cell mobilization by the systemic use of granulocyte colony-stimulating factor (GCSF) improves wound bed preparation. Iwamoto S; Lin X; Ramirez R; Carson P; Fiore D; Goodrich J; Yufit T; Falanga V Int J Low Extrem Wounds; 2013 Dec; 12(4):256-64. PubMed ID: 24275756 [TBL] [Abstract][Full Text] [Related]
9. Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds. Upton Z; Wallace HJ; Shooter GK; van Lonkhuyzen DR; Yeoh-Ellerton S; Rayment EA; Fleming JM; Broszczak D; Queen D; Sibbald RG; Leavesley DI; Stacey MC Int Wound J; 2011 Oct; 8(5):522-32. PubMed ID: 21914133 [TBL] [Abstract][Full Text] [Related]
11. Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises? Papanas N; Maltezos E Int J Low Extrem Wounds; 2007 Mar; 6(1):37-53. PubMed ID: 17344201 [TBL] [Abstract][Full Text] [Related]
12. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. O'Meara S; Cullum N; Majid M; Sheldon T Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391 [TBL] [Abstract][Full Text] [Related]